anti-TPO Clone 7G1-A9 antibody product blog
Tags: Antibody; Monoclonal Antibody; TPO Clone 7G1-A9; anti-TPO Clone 7G1-A9 antibody;
The TPO Clone 7G1-A9 n/a (Catalog #MBS350070) is an Antibody and is intended for research purposes only. The product is available for immediate purchase. The Anti-human Thrombopoietin (TPO) Monoclonal Antibody 7G1-A9 reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s TPO Clone 7G1-A9 can be used in a range of immunoassay formats including, but not limited to, ELISA.ELISA: The monoclonal antibody in this IgM fraction has been found by indirect ELISA to bind to recombinant human TPO and hTPO(244-277). Titration experiments by indirect ELISA show that 100 ng of this IgM will yield an OD of greater than 2.0 under standard assay conditions. Researchers should empirically determine the suitability of the TPO Clone 7G1-A9 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
This purified IgM fraction was isolated from ascites fluid containing mouse monoclonal antibody 7G1-A9 raised against human TPO. The 50?g of IgM has been packaged in 100?l of 10mg/ml BSA in PBS as carrier protein. This monoclonal antibody has been found to bind specifically to human TPO by ELISA and blotting techniques. By epitope mapping with synthetic peptides. it was found that this antibody binds to residues 244-277 of human TPO.
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing TPO Clone 7G1-A9 are readily searchable from our website. Different antibodies against the same target such as TPO Clone 7G1-A9 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.